Differential efficacy of protease inhibitors against HCV genotypes 2a, 3a, 5a, and 6a NS3/4A protease recombinant viruses

Gastroenterology

Volumn 141, Issue 3, 2011, Pages 1067-1079

  Gottwein, Judith M ^a,b   Scheel, Troels K H ^a,b   Jensen, Tanja B ^a,b   Ghanem, Lubna ^a,b   Bukh, Jens ^a,b  

^a Mental Health Services CPH   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Interferon; ITMN 191; SCH503034; TMC435351; VX 951

Indexed keywords

ALPHA2 INTERFERON; ANTIVIRUS AGENT; BMS 790052; BOCEPREVIR; DANOPREVIR; NONSTRUCTURAL PROTEIN 3 PROTEASE; PROTEINASE INHIBITOR; TELAPREVIR; TMC 435350; UNCLASSIFIED DRUG; VANIPREVIR; VIRUS ENZYME;

ANTIVIRAL ACTIVITY; ANTIVIRAL SUSCEPTIBILITY; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENCY; DRUG SCREENING; GENETIC STABILITY; GENETIC TRANSFECTION; GENOTYPE; HEPATITIS C VIRUS; HEPATOMA CELL; HUMAN; HUMAN CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS CULTURE; VIRUS INFECTIVITY; VIRUS MUTANT; VIRUS RECOMBINANT; VIRUS TITRATION; VIRUS VIABILITY;

EID: 80052123459     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2011.06.004     Document Type: Article

References (25)

1. P. Simmonds, J. Bukh, and C. Combet Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes Hepatology 42 2005 962 973 (Pubitemid 41401136)
2. M.P. Manns, H. Wedemeyer, and M. Cornberg Treating viral hepatitis C: efficacy, side effects, and complications Gut 55 2006 1350 1359 (Pubitemid 44277369)
3. N. Antaki, A. Craxi, and S. Kamal The neglected hepatitis C virus genotypes 4, 5 and 6: an international consensus report Liver Int 30 2010 342 355
4. J.M. Gottwein, and J. Bukh Cutting the gordian knot-development and biological relevance of hepatitis C virus cell culture systems Adv Virus Res 71 2008 51 133
5. J.M. Pawlotsky, S. Chevaliez, and J.G. McHutchison The hepatitis C virus life cycle as a target for new antiviral therapies Gastroenterology 132 2007 1979 1998 (Pubitemid 46695724)
6. C. Sarrazin, and S. Zeuzem Resistance to direct antiviral agents in patients with hepatitis C virus infection Gastroenterology 138 2010 447 462
7. L.B. Dustin, and C.M. Rice Flying under the radar: the immunobiology of hepatitis C Annu Rev Immunol 25 2007 71 99 (Pubitemid 46697903)
8. R.K. Beran, B.D. Lindenbach, and A.M. Pyle The NS4A protein of hepatitis C virus promotes RNA-coupled ATP hydrolysis by the NS3 helicase J Virol 83 2009 3268 3275
9. B.D. Lindenbach, B.M. Pragai, and R. Montserret The C terminus of hepatitis C virus NS4A encodes an electrostatic switch that regulates NS5A hyperphosphorylation and viral replication J Virol 81 2007 8905 8918 (Pubitemid 47311435)
10. Y. Ma, M. Anantpadma, and J.M. Timpe Hepatitis C virus NS2 protein serves as a scaffold for virus assembly by interacting with both structural and nonstructural proteins J Virol 85 2011 86 97
11. V. Jirasko, R. Montserret, and J.Y. Lee Structural and functional studies of nonstructural protein 2 of the hepatitis C virus reveal its key role as organizer of virion assembly PLoS Pathog 6 2010 e1001233
12. K.A. Stapleford, and B.D. Lindenbach Hepatitis C virus NS2 coordinates virus particle assembly through physical interactions with the E1-E2 glycoprotein and NS3-NS4A enzyme complexes J Virol 85 2011 1706 1717
13. T. Wakita, T. Pietschmann, and T. Kato Production of infectious hepatitis C virus in tissue culture from a cloned viral genome Nat Med 11 2005 791 796 (Pubitemid 41021213)
14. B.D. Lindenbach, M.J. Evans, and A.J. Syder Complete replication of hepatitis C virus in cell culture Science 309 2005 623 626 (Pubitemid 41033648)
15. M. Yi, R.A. Villanueva, and D.L. Thomas Production of infectious genotype 1a hepatitis C virus (Hutchinson strain) in cultured human hepatoma cells Proc Natl Acad Sci U S A 103 2006 2310 2315 (Pubitemid 43271666)
16. T. Pietschmann, M. Zayas, and P. Meuleman Production of infectious genotype 1b virus particles in cell culture and impairment by replication enhancing mutations PLoS Pathog 5 2009 e1000475
17. J. Bukh, P. Meuleman, and R. Tellier Challenge pools of hepatitis C virus genotypes 1-6 prototype strains: replication fitness and pathogenicity in chimpanzees and human liver-chimeric mouse models J Infect Dis 201 2010 1381 1389
18. J.M. Gottwein, T.K. Scheel, and A.M. Hoegh Robust hepatitis C genotype 3a cell culture releasing adapted intergenotypic 3a/2a (S52/JFH1) viruses Gastroenterology 133 2007 1614 1626 (Pubitemid 350029736)
19. T.K. Scheel, J.M. Gottwein, and L.S. Mikkelsen Recombinant HCV Variants with NS5A from genotypes 1-7 have different sensitivities to an NS5A inhibitor but not interferon-α Gastroenterology 140 2011 1032 1042
20. J.M. Gottwein, T.K. Scheel, and T.B. Jensen Development and characterization of hepatitis C virus genotype 1-7 cell culture systems: role of CD81 and scavenger receptor class B type I and effect of antiviral drugs Hepatology 49 2009 364 377
21. I. Imhof, and P. Simmonds Development of an intergenotypic hepatitis C virus (HCV) cell culture method to assess antiviral susceptibilities and resistance development of HCV NS3 protease genes from HCV genotypes 1 to 6 J Virol 84 2010 4597 4610
22. G. Patargias, N. Zitzmann, and R. Dwek Protein-protein interactions: modeling the hepatitis C virus ion channel p7 J Med Chem 49 2006 648 655 (Pubitemid 43157494)
23. V. Brass, J.M. Berke, and R. Montserret Structural determinants for membrane association and dynamic organization of the hepatitis C virus NS3-4A complex Proc Natl Acad Sci U S A 105 2008 14545 14550
24. X. Tong, Z. Guo, and J. Wright-Minogue Impact of naturally occurring variants of HCV protease on the binding of different classes of protease inhibitors Biochemistry 45 2006 1353 1361 (Pubitemid 43214800)
25. G.R. Foster, C. Hezode, and J.-P. Bronowicki Activity of telapravir alone or in combination with peginterferon alfa-2a and ribavirin in treatment-naive genotype 2 and 3 hepatitis-C patients: interim results of study C209 J Hepatol 50 2009 S22-S22